News for Healthier Living

Semaglutide More Effective at Lowering Risk for Stroke and Other Cardiovascular Outcomes Compared to Empagliflozin

Two target trial emulation studies compared mortality and cardiovascular risks in adult patients treated with semaglutide or dulaglutide versus empagliflozin.

June 16, 2025


June 27 2025

June 26 2025

June 25 2025

June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025

June 18 2025

June 17 2025

June 16 2025

June 15 2025

June 14 2025

June 13 2025